New injury puts Daisuke Matsuzaka’s comeback from Tommy John surgery on hold

6 Comments

Daisuke Matsuzaka’s minor-league rehab assignment and return from Tommy John elbow surgery has been put on hold because of what the Red Sox are calling pain in his trapezius muscle.

At one point it looked like Matsuzaka was on the verge of coming off the disabled list and rejoining the Red Sox’s rotation, but manager Bobby Valentine told Peter Abraham of the Boston Globe that the new injury “has been nagging him for quite a while and we’ve got to make sure that that’s 100 percent before he’s going out there again.”

In other words, don’t count on seeing Matsuzaka in Boston for a while. His rehab stint had been a mixed bag, with a strong 22/6 K/BB ratio in 25 innings coming along with a 4.62 ERA and .260 opponents’ batting average.

Steven Matz underwent season-ending surgery

Getty Images
Leave a comment

Steven Matz underwent season-ending surgery on his left elbow today. The procedure was to reposition a compressed nerve in his elbow.

Matz, 26, has struggled over 13 starts, posting a 6.08 ERA with a 48/19 K/BB ratio in 66.2 innings. That line was, obviously, a function of the bum nerve in the bum elbow. Trouble aside, Matz is expected to be ready for Opening Day in 2018.

The Mariners Designate Leonys Martin for Assignment. Again.

Getty Images
Leave a comment

Back in April the Mariners designated outfielder Leonys Martin for assignment. He cleared waivers, accepted an assignment to Triple-A Tacoma and proceeded to hit .312/.352/.506 in 84 minor league games, leading to the Mariners calling him up on July 30.

In 19 games since then he’s hit a bit better than he did back in April, but not great: .230/.266/.426. So they just designated him for assignment again. The Rainers only have six more games this season, so he’s likely not going back there. Given that he’s arbitration eligible and the M’s are unlikely to tender him a contract, he’s likely to elect free agency once he clears waivers. Which he will, because he’s making nearly $5 million this year.

Odd year for Martin, who will likely be competing for a roster spot someplace next spring.